SPECTRUM PHARMACEUTICALS INC Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Spectrum Pharmaceuticals Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q1 2023.
  • Spectrum Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2023 was -$5.01M, a 67.6% increase year-over-year.
  • Spectrum Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2023 was -$65M, a 53.1% increase year-over-year.
  • Spectrum Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$75.4M, a 52.5% increase from 2021.
  • Spectrum Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$159M, a 1.39% increase from 2020.
  • Spectrum Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2020 was -$161M, a 42.8% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$65M -$5.01M +$10.4M +67.6% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 -$75.4M -$8.99M +$30.7M +77.4% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-31
Q3 2022 -$106M -$21.9M +$11.2M +33.7% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 -$117M -$29M +$21.1M +42.1% Apr 1, 2022 Jun 30, 2022 10-Q 2022-11-14
Q1 2022 -$138M -$15.4M +$20.3M +56.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$159M -$39.7M +$44K +0.11% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$159M -$33.1M +$15.4M +31.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$174M -$50.1M -$18M -56.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$156M -$35.7M +$4.88M +12% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$161M -$39.8M +$441K +1.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-18
Q3 2020 -$161M -$48.5M -$22.5M -86.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$139M -$32.1M -$3.69M -13% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-10
Q1 2020 -$135M -$40.6M -$21.3M -111% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-10
Q4 2019 -$114M -$40.2M +$12.9M +24.3% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-02
Q3 2019 -$127M -$26M +$43.2M +62.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 -$170M -$28.4M -$43.3M -291% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-04
Q1 2019 -$127M -$19.3M -$16K -0.08% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-04
Q4 2018 -$127M -$53.1M -$24.6M -86% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-02
Q3 2018 -$102M -$69.2M -$50.9M -278% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-02
Q2 2018 -$51.2M $14.9M +$35.7M Apr 1, 2018 Jun 30, 2018 10-K 2020-03-02
Q1 2018 -$86.9M -$19.2M +$4.3M +18.3% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-02
Q4 2017 -$91.2M -$28.6M -$10.5M -57.7% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-28
Q3 2017 -$80.8M -$18.3M -$653K -3.7% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-28
Q2 2017 -$80.1M -$20.9M +$3.64M +14.9% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-28
Q1 2017 -$83.8M -$23.5M -$14M -147% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-28
Q4 2016 -$69.8M -$18.1M -$14M -336% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-07
Q3 2016 -$55.8M -$17.6M +$1.08M +5.79% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-07
Q2 2016 -$56.9M -$24.5M -$22.2M -944% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-07
Q1 2016 -$34.8M -$9.53M +$16M +62.7% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-07
Q4 2015 -$50.8M -$4.15M -$1.18M -39.6% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-14
Q3 2015 -$49.6M -$18.7M -$7.19M -62.3% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-14
Q2 2015 -$42.4M -$2.35M +$1.22M +34.2% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-14
Q1 2015 -$43.6M -$25.6M +$2.08M +7.52% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-14
Q4 2014 -$45.7M -$2.98M +$36.2M +92.4% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-14
Q3 2014 -$81.9M -$11.5M -$3.73M -47.7% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-14
Q2 2014 -$78.2M -$3.56M +$6.16M +63.3% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-14
Q1 2014 -$84.3M -$27.6M -$22.2M -409% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-14
Q4 2013 -$62.1M -$39.2M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-13
Q3 2013 -$7.81M Jul 1, 2013 Sep 30, 2013 10-K 2015-03-13
Q2 2013 -$9.72M Apr 1, 2013 Jun 30, 2013 10-K 2015-03-13
Q1 2013 -$5.44M Jan 1, 2013 Mar 31, 2013 10-K 2015-03-13
Q3 2011 $20.3M +$24.8M Jul 1, 2011 Sep 30, 2011 10-Q 2011-10-28
Q2 2011 $7.2M +$16.9M Apr 1, 2011 Jun 30, 2011 10-Q 2011-08-04
Q3 2010 -$4.59M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-28
Q2 2010 -$9.68M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.